Comparing cardiovascular risk factors in older persons with mild cognitive impairment and lifetime history of major depressive disorder.


Journal

International psychogeriatrics
ISSN: 1741-203X
Titre abrégé: Int Psychogeriatr
Pays: England
ID NLM: 9007918

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 30 3 2021
medline: 29 6 2022
entrez: 29 3 2021
Statut: ppublish

Résumé

To compare the prevalence of select cardiovascular risk factors (CVRFs) in patients with mild cognitive impairment (MCI) versus lifetime history of major depression disorder (MDD) and a normal comparison group using baseline data from the Prevention of Alzheimer's Dementia with Cognitive Remediation plus Transcranial Direct Current Stimulation (PACt-MD) study. Baseline data from a multi-centered intervention study of older adults with MCI, history of MDD, or combined MCI and history of MDD (PACt-MD) were analyzed. Community-based multi-centered study based in Toronto across 5 academic sites. Older adults with MCI, history of MDD, or combined MCI and history of MDD and healthy controls. We examined the baseline distribution of smoking, hypertension and diabetes in three groups of participants aged 60+ years in the PACt-MD cohort study: MCI (n = 278), MDD (n = 95), and healthy older controls (n = 81). Generalized linear models were fitted to study the effect of CVRFs on MCI and MDD as well as neuropsychological composite scores. A higher odds of hypertension among the MCI cohort compared to healthy controls (p < .05) was noted in unadjusted analysis. Statistical significance level was lost on adjusting for age, sex and education (p > .05). A history of hypertension was associated with lower performance in composite executive function (p < .05) and overall composite neuropsychological test score (p < .05) among a pooled cohort with MCI or MDD. This study reinforces the importance of treating modifiable CVRFs, specifically hypertension, as a means of mitigating cognitive decline in patients with at-risk cognitive conditions.

Identifiants

pubmed: 33775259
pii: S1041610221000259
doi: 10.1017/S1041610221000259
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

563-569

Commentaires et corrections

Type : CommentIn

Auteurs

Wael K Karameh (WK)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, Toronto, Canada.
Keenan Research Centre for Biomedical Science of St. Michael's Hospital, St. Michael's Hospital, Toronto, Canada.
St. Michael's Hospital, Toronto, Canada.

Ines Kortebi (I)

University of Toronto, Toronto, Canada.

Sanjeev Kumar (S)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, Toronto, Canada.

Damien Gallagher (D)

University of Toronto, Toronto, Canada.
Sunnybrook Health Sciences Centre, Toronto, Canada.

Angela Golas (A)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, Toronto, Canada.
St. Michael's Hospital, Toronto, Canada.

Krista L Lanctôt (KL)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Sunnybrook Health Sciences Centre, Toronto, Canada.

Meryl A Butters (MA)

Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, USA.

Christopher R Bowie (CR)

Centre for Addiction and Mental Health, Toronto, Canada.
Queen's University, Kingston, Canada.

Alastair Flint (A)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Mental Health, University Health Network, Toronto, Canada.

Tarek Rajji (T)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, Toronto, Canada.

Nathan Herrmann (N)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Sunnybrook Health Sciences Centre, Toronto, Canada.

Bruce G Pollock (BG)

Campbell Family Mental Health Research Institute, Division of Geriatric Psychiatry, Centre for Addiction and Mental Health, Toronto, Canada.

Benoit Mulsant (B)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, Toronto, Canada.

Linda Mah (L)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Rotman Research Institute, Baycrest Health Sciences Centre, Toronto, Canada.

David G Munoz (DG)

Keenan Research Centre for Biomedical Science of St. Michael's Hospital, St. Michael's Hospital, Toronto, Canada.
University of Toronto, Toronto, Canada.

Tom A Schweizer (TA)

Keenan Research Centre for Biomedical Science of St. Michael's Hospital, St. Michael's Hospital, Toronto, Canada.
University of Toronto, Toronto, Canada.

Corinne E Fischer (CE)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Keenan Research Centre for Biomedical Science of St. Michael's Hospital, St. Michael's Hospital, Toronto, Canada.
St. Michael's Hospital, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH